AIFF
FIREFLY NEUROSCIENCE, INC.
NASDAQ · Technology · Software - Application · CA
$1.00
−1.96%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.03
From 52W high−66.89%
Volume72148.00
Market cap$15.69M
P/E (TTM)—
P/S (TTM)8.7x
Div yield—
Key dataOct 19, 2026
Open
$1.03
From 52W high
−66.89%
Volume
72148.00
Market cap
$15.69M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.7x
P/E (TTM)
—
RSI (14)
39.7
MomentumView details →
1D Return
−1.96%
YTD Return
+16.05%
SummaryUpdated Jun 1, 2026
Firefly Neuroscience, Inc. (NASDAQ:AIFF) is a Canadian medical technology and artificial intelligence company founded in 2002 and based in Toronto. The company develops neuroscientific solutions designed to improve diagnostic and treatment outcomes for patients suffering from mental illnesses and neurological disorders. Despite being publicly traded since 2002, Firefly remains in the early commercialization stage of its primary product offering, with minimal revenue generation and significant ongoing losses as it works to establish market presence in the specialized field of brain network analytics.
Similar companies
Latest newsMore news →
Firefly and NeuroSigma partnered to expand access to NeuroSigma's second-generation Monarch eTNS System through Firefly's nationwide network of Evoke clinicians.25d agoFirefly Neuroscience's Evoke platform was selected to integrate objective brain-function insights into Radial's AI-native operating system for brain medicine.33d agoFirefly Neuroscience, Inc. appointed Jessica Paz as Chief Accounting Officer, effective September 8, 2026, with a base salary of $215,000 and an option to purchase 50,000 shares.35d ago